Long-term results of hypofractionated radiation therapy for breast cancer. 2010

Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada. tim.whelan@jcc.hhsc.ca

BACKGROUND The optimal fractionation schedule for whole-breast irradiation after breast-conserving surgery is unknown. METHODS We conducted a study to determine whether a hypofractionated 3-week schedule of whole-breast irradiation is as effective as a 5-week schedule. Women with invasive breast cancer who had undergone breast-conserving surgery and in whom resection margins were clear and axillary lymph nodes were negative were randomly assigned to receive whole-breast irradiation either at a standard dose of 50.0 Gy in 25 fractions over a period of 35 days (the control group) or at a dose of 42.5 Gy in 16 fractions over a period of 22 days (the hypofractionated-radiation group). RESULTS The risk of local recurrence at 10 years was 6.7% among the 612 women assigned to standard irradiation as compared with 6.2% among the 622 women assigned to the hypofractionated regimen (absolute difference, 0.5 percentage points; 95% confidence interval [CI], -2.5 to 3.5). At 10 years, 71.3% of women in the control group as compared with 69.8% of the women in the hypofractionated-radiation group had a good or excellent cosmetic outcome (absolute difference, 1.5 percentage points; 95% CI, -6.9 to 9.8). CONCLUSIONS Ten years after treatment, accelerated, hypofractionated whole-breast irradiation was not inferior to standard radiation treatment in women who had undergone breast-conserving surgery for invasive breast cancer with clear surgical margins and negative axillary nodes. (ClinicalTrials.gov number, NCT00156052.)

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004954 Esthetics The branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc. Aesthetics
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015412 Mastectomy, Segmental Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor. Breast-Conserving Surgery,Lumpectomy,Partial Mastectomy,Breast Conservation Therapy,Breast Quadrantectomy,Breast-Sparing Surgery,Limited Resection Mastectomy,Local Excision Mastectomy,Segmentectomy,Surgery, Breast-Conserving,Breast Conservation Therapies,Breast Conserving Surgery,Breast Quadrantectomies,Breast Sparing Surgery,Breast-Conserving Surgeries,Breast-Sparing Surgeries,Conservation Therapies, Breast,Conservation Therapy, Breast,Limited Resection Mastectomies,Local Excision Mastectomies,Lumpectomies,Mastectomies, Limited Resection,Mastectomies, Local Excision,Mastectomies, Partial,Mastectomies, Segmental,Mastectomy, Limited Resection,Mastectomy, Local Excision,Mastectomy, Partial,Partial Mastectomies,Quadrantectomies, Breast,Quadrantectomy, Breast,Segmental Mastectomies,Segmental Mastectomy,Segmentectomies,Surgeries, Breast-Conserving,Surgeries, Breast-Sparing,Surgery, Breast Conserving,Surgery, Breast-Sparing
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard

Related Publications

Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
August 2016, Tumori,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
October 2013, International journal of radiation oncology, biology, physics,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
August 2001, International journal of cancer,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
January 2005, International journal of radiation oncology, biology, physics,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
May 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
November 2012, International journal of radiation oncology, biology, physics,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
February 1989, Archives of surgery (Chicago, Ill. : 1960),
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
June 1996, Annals of surgery,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
December 2020, Journal of medical imaging and radiation oncology,
Timothy J Whelan, and Jean-Philippe Pignol, and Mark N Levine, and Jim A Julian, and Robert MacKenzie, and Sameer Parpia, and Wendy Shelley, and Laval Grimard, and Julie Bowen, and Himu Lukka, and Francisco Perera, and Anthony Fyles, and Ken Schneider, and Sunil Gulavita, and Carolyn Freeman
August 1995, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!